URCH Publishing
Since 2001, URCH Publishing has been busy researching, writing and publishing high quality market reports covering issues and markets in the global healthcare, pharmaceuticals and chemicals industry. All publications and information products are carefully researched by expert authors and written in a clear and succinct style. URCH prides itself on always offering quality products, directly relevant to today’s business world. All publications are based on high quality analysis, informed opinion and both primary and secondary research.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Graphite Digital
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences through meaningful digital experiences. Our teams of specialists help clients…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Healthcare Research Worldwide
We are market research experts in the healthcare, pharmaceutical, device and diagnostics space, and have a wealth of experience in a wide range of therapy areas. Our scientifically grounded approaches…
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Origins – The Patient Focused Specialists
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Visions4Health
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
The brand strategy revolution
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need.
How Medisafe is using AI to improve patient adherence
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.
Downloadable Pack: Understanding Multiple Sclerosis
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.
Six factors that drive a multiple sclerosis patient’s choice of disease-modifying therapy
White Papers and Resources | March 22, 2019 | Blue Latitude Health
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.
Innovative approaches in the treatment of multiple sclerosis
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Blue Latitude Health Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon.
Mobilising the public to combat the antimicrobial resistance crisis
White Papers and Resources | March 22, 2019 | Blue Latitude Health
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines...
Leading Edge, a Lucid Group company, strengthens its senior client services team
Press Releases | March 21, 2019 | Lucid Group Communications Limited
Leading Edge, a Lucid Group company, is delighted to announce the appointment of its new Lead Client Partnership Director, Frances O’Connor.Frances is an experienced strategic healthcare communicator with expertise in...
From Cowgirl to Medical Writer – How did that happen?
Press Releases | March 20, 2019 | Lucid Group Communications Limited
Amy Jackson, Editorial Director, Lucid Group discusses her unlikely path into Medical Communications.
Measures for measures
Press Releases | March 15, 2019 | Lucid Group Communications Limited
Why pharma’s marketing metrics must close the loop
My adventure into the world of Medcomms and Lucid’s Futures Academy
Press Releases | March 14, 2019 | Lucid Group Communications Limited
After finishing my PhD, I was disillusioned with the lab. I felt that I wanted more out of my career than working on one protein, in one pathway, for the...